Trexquant Investment LP bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The fund bought 49,593 shares of the company's stock, valued at approximately $8,054,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Brooklyn Investment Group boosted its position in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares in the last quarter. Continuum Advisory LLC grew its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares during the period. Millstone Evans Group LLC purchased a new stake in shares of Clorox during the 4th quarter valued at $31,000. Asset Planning Inc purchased a new stake in Clorox during the fourth quarter valued at about $32,000. Finally, Halbert Hargrove Global Advisors LLC acquired a new stake in Clorox during the 4th quarter worth approximately $36,000. Institutional investors and hedge funds own 78.53% of the company's stock.
Clorox Stock Performance
Shares of NYSE:CLX traded up $3.44 during trading on Wednesday, reaching $139.84. 1,888,622 shares of the company's stock traded hands, compared to its average volume of 1,292,542. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The company has a 50 day moving average of $147.91 and a 200-day moving average of $157.56. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market capitalization of $17.23 billion, a P/E ratio of 38.21, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61.
Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the business posted $2.16 EPS. On average, equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is 133.33%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a research report on Sunday, January 5th. Wells Fargo & Company reduced their target price on shares of Clorox from $161.00 to $155.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 2nd. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a report on Wednesday, February 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, Barclays lowered their target price on Clorox from $140.00 to $139.00 and set an "underweight" rating for the company in a research note on Thursday, March 27th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $159.00.
View Our Latest Stock Report on CLX
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.